Rockefeller Capital Management L.P. Acquires 252,200 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)

Rockefeller Capital Management L.P. boosted its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC - Free Report) by 140.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 431,856 shares of the medical technology company's stock after acquiring an additional 252,200 shares during the period. Rockefeller Capital Management L.P. owned 0.30% of Alphatec worth $2,401,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of ATEC. Net Worth Advisory Group purchased a new position in shares of Alphatec during the third quarter valued at approximately $76,000. Comerica Bank lifted its stake in shares of Alphatec by 64.8% in the first quarter. Comerica Bank now owns 6,443 shares of the medical technology company's stock worth $89,000 after buying an additional 2,534 shares in the last quarter. Van ECK Associates Corp raised its holdings in Alphatec by 57.0% in the 3rd quarter. Van ECK Associates Corp now owns 19,273 shares of the medical technology company's stock worth $99,000 after acquiring an additional 6,998 shares during the last quarter. Tempus Wealth Planning LLC bought a new position in Alphatec in the 3rd quarter valued at approximately $107,000. Finally, Atria Investments Inc boosted its stake in Alphatec by 8.0% during the 3rd quarter. Atria Investments Inc now owns 19,609 shares of the medical technology company's stock valued at $109,000 after purchasing an additional 1,460 shares during the last quarter. Institutional investors own 66.35% of the company's stock.

Alphatec Stock Performance

Shares of NASDAQ:ATEC traded up $0.04 during mid-day trading on Friday, reaching $9.63. 1,196,167 shares of the company traded hands, compared to its average volume of 1,713,358. The company's 50 day moving average price is $7.55 and its 200-day moving average price is $8.16. The firm has a market cap of $1.37 billion, a PE ratio of -7.52 and a beta of 1.38. Alphatec Holdings, Inc. has a 52 week low of $4.88 and a 52 week high of $17.34. The company has a debt-to-equity ratio of 30.21, a current ratio of 2.32 and a quick ratio of 1.15.

Wall Street Analysts Forecast Growth

ATEC has been the topic of a number of research analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $13.00 price target on shares of Alphatec in a report on Thursday, October 31st. Lake Street Capital dropped their price target on shares of Alphatec from $32.00 to $18.00 and set a "buy" rating on the stock in a report on Tuesday, September 3rd. Barclays boosted their price objective on shares of Alphatec from $19.00 to $20.00 and gave the company an "overweight" rating in a report on Tuesday, November 19th. Canaccord Genuity Group restated a "buy" rating and issued a $20.00 target price on shares of Alphatec in a report on Friday, August 30th. Finally, HC Wainwright reiterated a "buy" rating and set a $20.00 target price on shares of Alphatec in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $17.11.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.